Eupraxia Pharmaceuticals Inc (EPRX) — Financial Flexibility Index
Eupraxia Pharmaceuticals Inc (EPRX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of CA$-4.45 Million (operating CF CA$-4.51 Million minus capex CA$60.38K) represents -1% of total liabilities (CA$5.43 Million). Check Eupraxia Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eupraxia Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Eupraxia Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see EPRX cash flow metrics.
Annual Financial Flexibility Index for Eupraxia Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Eupraxia Pharmaceuticals Inc. Explore how well can Eupraxia Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.70x | CA$-29.89 Million | CA$-29.99 Million | CA$4.46 Million | ▼ -514.5% |
| 2023 | -1.09x | CA$-27.84 Million | CA$-27.92 Million | CA$25.55 Million | ▲ +14.4% |
| 2022 | -1.27x | CA$-18.47 Million | CA$-18.78 Million | CA$14.51 Million | ▼ -4.5% |
| 2021 | -1.22x | CA$-14.21 Million | CA$-14.64 Million | CA$11.67 Million | ▼ -101558.9% |
| 2020 | 0.00x | CA$27.75K | CA$-403.93K | CA$23.12 Million | ▲ +100.5% |
| 2019 | -0.24x | CA$-5.16 Million | CA$-5.17 Million | CA$21.42 Million | ▲ +57.7% |
| 2018 | -0.57x | CA$-8.18 Million | CA$-8.32 Million | CA$14.34 Million | ▲ +91.6% |
| 2017 | -6.77x | CA$-4.98 Million | CA$-5.30 Million | CA$735.82K | — |